The effects of FK506 on neurologic and histopathologic outcome after transient spinal cord ischemia induced by aortic cross-clamping in rats

Anesthesia and Analgesia

Volumn 92, Issue 5, 2001, Pages 1237-1244

  Lang Lazdunski, Loïc ^a,c   Heurteaux, Catherine ^b   Dupont, Hervé ^a   Rouelle, Danielle ^a   Widmann, Catherine ^b   Mantz, Jean ^a  

^a BICHAT HOSPITAL   (France)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; DRUG EFFECT; GRAY MATTER; HISTOPATHOLOGY; MALE; NEUROPROTECTION; NONHUMAN; PARAPLEGIA; PRIORITY JOURNAL; RAT; REPERFUSION; SPINAL CORD ISCHEMIA;

EID: 0035041217     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200105000-00029     Document Type: Article

References (30)

1. Protection of the spinal cord during surgery of thoracoabdominal aortic aneurysms
2. Effect of extended cross-clamp time during thoracoabdominal aortic aneurysm repair
3. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients
4. Neuroprotective actions of FK506 in experimental stroke: In vivo evidence against an antiexcitotoxic mechanism
5. Neuroprotective FK506 does not alter in vivo nitric oxide production during ischemia and early reperfusion in rats
6. An immunosuppressant, FK506, protects hippocampal neurons from forebrain ischemia in the Mongolian gerbil
7. Neuroprotective effect of FK506, an immunosuppressant, on transient global ischemia in gerbil
8. Tacrolimus (FK506) increases neuronal expression of GAP-43 and improves functional recovery after spinal cord injury in rats
9. Paraplegia in the rat induced by aortic cross-clamping: Model characterization and glucose exacerbation of neurologic deficit
10. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
11. The cytoarchitectonic organization of the spinal cord in the cat
12. Effect of proximal arterial perfusion pressure on function, spinal cord blood flow, and histopathologic changes after increasing intervals of aortic occlusion in the rat
13. Spinal cord ischemic injury: Development of a new model in the rat
14. Selective vulnerability of white matter during spinal cord ischemia
15. Ischemic spinal cord injury induced by aortic cross-clamping: Prevention by riluzole
16. Spinal cord vascularity. IV. The spinal cord arteries in the rat
17. Acidosis and ischemic brain damage
18. The immunosuppressant drug FK506 ameliorates secondary mitochondrial dysfunction following transient focal cerebral ischemia in the rat
19. FK506 prevents stroke-induced generation of ceramide and apoptosis signaling
20. Tacrolimus (FK506) attenuates leukocyte accumulation after transient retinal ischemia
21. Protective effects of FK506 on ischemia/reperfusion-induced myocardial damage in canine heart
22. Inhibitory effect of cyclosporin A and FK506 on nitric oxide production by cultured macrophages: Evidence of a direct effect on nitric oxide synthase activity
23. Bright and dark sides of nitric oxide in ischemic brain injury
24. Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A
25. Memantine for prevention of spinal cord injury in a rabbit model
26. Prevention of ischemic spinal cord injury: Comparative effects of magnesium sulfate and riluzole
27. Suppressed endothelin-1 production by FK506 and cyclosporin A in ischemia/reperfusion of rat small intestine
28. FK506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats
29. The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats